Understanding how immune cells respond to infections
Functional Implications of Tfh Cell Heterogeneity after Infection
This study is looking at how certain immune cells, called T follicular helper cells, work after infections to help your body build long-lasting protection, which could lead to better vaccines and treatments for diseases like COVID-19.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10993128 on NIH RePORTER |
What this research studies
This research investigates the behavior of specific immune cells called T follicular helper (Tfh) cells after infections, particularly focusing on their role in generating long-lasting immunity. By examining how these cells differentiate and function, the study aims to uncover the mechanisms that lead to the production of protective antibodies and memory B cells, which are crucial for effective vaccination. The research employs advanced techniques to analyze immune responses in the context of infections like the novel coronavirus, aiming to improve vaccine strategies. Patients may benefit from insights that could lead to more effective vaccines and treatments for infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with or vaccinated against the novel coronavirus and are interested in understanding their immune response.
Not a fit: Patients who have not been exposed to the novel coronavirus or who do not have a significant immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide long-lasting immunity against infectious diseases.
How similar studies have performed: Previous research has shown success in understanding immune responses to infections, indicating that this approach has potential for significant advancements.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Randall, Troy D — University of Alabama at Birmingham
- Study coordinator: Randall, Troy D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.